acetaminophen has been researched along with s 1033 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Shaker, ME | 1 |
| Menisy, GM; Suddek, GM; Zakaria, S | 1 |
1 review(s) available for acetaminophen and s 1033
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for acetaminophen and s 1033
| Article | Year |
|---|---|
Nilotinib interferes with the signalling pathways implicated in acetaminophen hepatotoxicity.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Protein-Tyrosine Kinases; Pyrimidines; Signal Transduction | 2014 |
Nilotinib alleviated acetaminophen-induced acute hepatic injury in mice through inhibiting HIF-1alpha/VEGF-signaling pathway.
Topics: Acetaminophen; Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Liver; Male; Mice; Oxidative Stress; Signal Transduction; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2022 |